
FDA Provides Positive Feedback on Tetra Bio-Pharma’s (OTC: TBPMF) Application for ARDS-003 Clinical Development in COVID-19 Patients
FDA acknowledged that the preclinical safety data are acceptable to file an Investigational New Drug Application (IND) aimed at treating hospitalized COVID-19 patients at risk of developing ARDS OTTAWA, ON / April 5, 2021 /Tetra […]